August 15 - 17, 2019 | San Francisco

Emerald Health Therapeutics

Booth: 113

company logo
Emerald Health Therapeutics, Inc. (TSXV: EMH; OTCQX: EMHTF) (Emerald) is a Health Canada Licensed Producer of medical cannabis and is significantly expanding production capacity in anticipation of the legal adult-use cannabis market in Canada, slated for October 17, 2018. Emerald's multi-phase expansion plan includes a joint venture of 1.1 million square feet with an additional 3.7 million square foot option, as well as 575K square feet in wholly owned, established/planned grow facilities. The vertically integrated, seed-to-sale enterprise combines core competencies in pharmaceutical innovation and large-scale agriculture. Our ambition is to be at the forefront of developing knowledge and products that provide wellness and health benefits from cannabis.

Speaker Schedule

Emerald Health Therapeutics: An Emerging Leader in the Global Cannabis Industry
August 23, 2018, 11:25 am - 11:45 am PDT

Presented by: Rob Hill, CPA, Chief Financial Officer, Emerald Health Therapeutics Inc.


The Endocannabi-What? The Medical (and Investment) Potential of Cannabis
August 25, 2018, 2:15 pm - 3:00 pm PDT

Presented by: Jim DeMesa, MD, MBA, Chief Executive Officer, Emerald Health Pharmaceuticals Inc.